| |
| |
|
| Insider
Information: |
Henel Rolf H |
| Relationship: |
Director |
| City: |
Danbury |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
74,500 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
74,500 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Penwest Pharmaceuticals Co |
PPCO |
Director |
2007-02-19 |
14,500 |
2003-09-04 |
0 |
Premium* |
|
|
Sciclone Pharmaceuticals Inc |
SCLN |
Director |
2009-05-14 |
60,000 |
2007-11-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
13 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SCLN |
Sciclone Pharmaceuticals ... |
Director |
– • – |
2009-05-14 |
4 |
OE |
$1.44 |
$14,400 |
D/D |
10,000 |
60,000 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
Director |
– • – |
2008-05-14 |
4 |
B |
$1.80 |
$9,000 |
D/D |
5,000 |
50,000 |
2.39 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
Director |
– • – |
2008-05-13 |
4 |
B |
$1.75 |
$61,372 |
D/D |
34,400 |
45,000 |
2.39 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
Director |
– • – |
2007-12-31 |
4 |
S |
$2.03 |
$19,509 |
D/D |
(9,400) |
10,600 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
Director |
– • – |
2007-12-28 |
4 |
B |
$2.26 |
$21,336 |
D/D |
9,400 |
20,000 |
2.39 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
Director |
– • – |
2007-11-23 |
4 |
B |
$1.85 |
$925 |
D/D |
500 |
10,600 |
2.31 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
Director |
– • – |
2007-11-20 |
4 |
B |
$1.81 |
$181 |
D/D |
100 |
10,100 |
2.31 |
- |
|
| PPCO |
Penwest Pharmaceuticals C... |
Director |
– • – |
2007-02-19 |
4 |
A |
$0.00 |
$0 |
D/D |
12,000 |
14,500 |
0 |
- |
|
| PPCO |
Penwest Pharmaceuticals C... |
Director |
– • – |
2006-11-17 |
4 |
D |
$17.58 |
$65,928 |
D/D |
(3,750) |
2,500 |
0 |
- |
|
| PPCO |
Penwest Pharmaceuticals C... |
Director |
– • – |
2006-11-15 |
4 |
D |
$16.74 |
$126,609 |
D/D |
(7,500) |
6,250 |
0 |
- |
|
| PPCO |
Penwest Pharmaceuticals C... |
Director |
– • – |
2003-11-25 |
4 |
D |
$14.75 |
$32,124 |
D/D |
(2,177) |
13,750 |
|
- |
|
| PPCO |
Penwest Pharmaceuticals C... |
Director |
– • – |
2003-09-04 |
4/A |
D |
$0.00 |
$0 |
D/D |
(0) |
15,927 |
|
- |
|
| PPCO |
Penwest Pharmaceuticals C... |
Director |
– • – |
2003-09-04 |
4 |
D |
$22.00 |
$47,905 |
D/D |
(2,177) |
13,750 |
|
- |
|
13 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
